Cancer Incidence for the City of Rochester, 2015-2019
Source: New York State Cancer Registry
Site of Cancer | Males and Females | Males | Females | ||||||
---|---|---|---|---|---|---|---|---|---|
Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | |
All Invasive Malignant Tumors | 1028.0 | 490.3 | 476.5-504.4 | 526.4 | 555.2 | 533.1-578.0 | 501.6 | 443.8 | 426.0-462.1 |
Oral cavity and pharynx | 27.2 | 12.5 | 10.5-14.9 | 19.0 | 19.3 | 15.4-23.8 | 8.2 | 6.7 | 4.8-9.2 |
Esophagus | 11.8 | 5.7 | 4.3-7.4 | 8.4 | 8.7 | 6.1-11.9 | 3.4 | 3.2 | 1.8-5.1 |
Stomach | 16.6 | 8.2 | 6.5-10.3 | 8.4 | 8.8 | 6.3-12.1 | 8.2 | 7.4 | 5.3-10.2 |
Colorectal | 83.8 | 40.9 | 37.0-45.2 | 44.8 | 47.0 | 40.8-53.9 | 39.0 | 35.9 | 30.9-41.5 |
Colon excluding rectum | 59.4 | 28.9 | 25.6-32.5 | 30.0 | 31.3 | 26.3-37.0 | 29.4 | 26.8 | 22.5-31.6 |
Rectum & rectosigmoid | 24.4 | 12.0 | 9.9-14.4 | 14.8 | 15.8 | 12.2-20.0 | 9.6 | 9.1 | 6.6-12.2 |
Liver / intrahepatic bile duct | 23.6 | 10.6 | 8.7-12.7 | 16.6 | 16.4 | 12.9-20.5 | 7.0 | 5.9 | 4.1-8.3 |
Pancreas | 30.0 | 14.7 | 12.4-17.4 | 14.0 | 15.1 | 11.6-19.3 | 16.0 | 14.5 | 11.4-18.2 |
Larynx | 11.4 | 5.1 | 3.9-6.7 | 9.0 | 9.1 | 6.5-12.3 | 2.4 | 2.1 | 1.1-3.7 |
Lung and bronchus | 157.0 | 74.7 | 69.4-80.3 | 82.8 | 89.5 | 80.6-99.1 | 74.2 | 64.1 | 57.6-71.2 |
Melanoma of the skin | 21.8 | 10.4 | 8.5-12.6 | 13.4 | 15.1 | 11.5-19.4 | 8.4 | 7.1 | 5.0-9.7 |
Female breast | 137.2 | 122.2 | 112.9-132.0 | ||||||
Cervix uteri | 8.6 | 8.3 | 5.9-11.2 | ||||||
Corpus uterus and NOS | 37.2 | 31.6 | 27.1-36.7 | ||||||
Ovary | 10.6 | 9.3 | 6.9-12.3 | ||||||
Prostate | 146.4 | 149.9 | 138.7-161.8 | ||||||
Testis | 5.8 | 5.0 | 3.2-7.3 | ||||||
Urinary bladder (incl. in situ) | 36.2 | 18.1 | 15.4-21.0 | 24.4 | 28.0 | 23.0-33.7 | 11.8 | 10.4 | 7.8-13.5 |
Kidney and renal pelvis | 49.4 | 23.4 | 20.5-26.6 | 31.0 | 30.7 | 25.9-36.2 | 18.4 | 16.9 | 13.5-20.9 |
Brain and other central nervous system | 12.4 | 5.6 | 4.3-7.3 | 6.6 | 6.8 | 4.6-9.6 | 5.8 | 4.8 | 3.2-7.0 |
Thyroid | 25.6 | 11.8 | 9.7-14.1 | 7.8 | 8.3 | 5.8-11.5 | 17.8 | 15.3 | 12.1-19.0 |
Hodgkin lymphoma | 6.2 | 2.7 | 1.8-3.9 | 4.0 | 3.6 | 2.2-5.8 | 2.2 | 1.8 | 0.9-3.4 |
Non-Hodgkin lymphomas | 35.0 | 17.4 | 14.8-20.2 | 19.0 | 20.6 | 16.4-25.4 | 16.0 | 15.0 | 11.8-18.8 |
Myeloma | 20.4 | 10.2 | 8.2-12.5 | 9.6 | 10.8 | 7.8-14.6 | 10.8 | 9.7 | 7.2-12.8 |
Leukemias | 23.6 | 11.6 | 9.6-14.0 | 13.8 | 15.3 | 11.7-19.5 | 9.8 | 8.4 | 6.1-11.2 |
Notes
- Incidence data are provisional, November 2021.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution. NOS = Not otherwise specified.